YMR046W-A Antibody

What is YMR046W-A and what cellular processes is it involved in?

YMR046W-A is a protein-coding gene in Saccharomyces cerevisiae (strain ATCC 204508/S288c, baker's yeast) with UniProt accession number Q6B0Y5. The protein is involved in specific cellular pathways within yeast metabolism and regulation. Current research indicates its potential role in stress response mechanisms, though this continues to be an active area of investigation. When designing experiments targeting this protein, researchers should consider its cellular localization, expression patterns under varying conditions, and potential interaction partners to properly contextualize findings .

What are the recommended primary applications for YMR046W-A antibody?

YMR046W-A antibody is primarily utilized in Western blotting, immunoprecipitation (IP), and immunocytochemistry (ICC) applications. The antibody demonstrates high specificity in detecting the target protein in yeast lysates and fixed samples. For Western blot applications, the recommended dilution range is 1:500-1:2000, while IP typically requires 2-5 μg of antibody per 500 μg of total protein. For ICC applications in fixed yeast cells, dilutions of 1:100-1:500 typically yield optimal results with minimal background. Validation experiments comparing wild-type and knockout strains are strongly recommended to confirm specificity .

How should I validate YMR046W-A antibody specificity before experiments?

Validation of YMR046W-A antibody specificity should follow a multi-tier approach. First, perform Western blot analysis using both wild-type yeast and YMR046W-A knockout strains to confirm the absence of signal in the latter. Second, conduct peptide competition assays where pre-incubation of the antibody with the immunizing peptide should abolish specific signals. Third, verify cross-reactivity profiles against related yeast strains (e.g., ATCC 204508/S288c vs. JAY291 or YJM789) to understand strain-specific detection limits. Finally, compare results with orthogonal detection methods such as mass spectrometry or RNA expression analysis to corroborate protein identification .

What is the optimal protein extraction protocol for detecting YMR046W-A in yeast cells?

The optimal extraction protocol for YMR046W-A detection requires special consideration due to the protein's characteristics. Use the following method for highest yield and preservation of epitope integrity:

• Harvest yeast cells during mid-log phase (OD600 = 0.6-0.8)

• Wash cells twice with ice-cold PBS

• Resuspend in lysis buffer containing:

  • 50 mM Tris-HCl (pH 7.5)

  • 150 mM NaCl

  • 1% Triton X-100

  • 0.1% SDS

  • 5 mM EDTA

  • Protease inhibitor cocktail

• Add glass beads (0.5 mm) at 1:1 ratio with cell pellet volume

• Perform 8 cycles of vortexing (30 seconds) followed by cooling on ice (30 seconds)

• Centrifuge at 12,000 × g for 10 minutes at 4°C

• Collect supernatant and determine protein concentration

This method consistently yields intact YMR046W-A protein with preserved epitopes for antibody recognition. For membrane-associated fractions, consider additional ultracentrifugation steps to separate subcellular compartments .

How can I optimize Western blot conditions for YMR046W-A antibody?

Optimizing Western blot conditions for YMR046W-A antibody requires attention to several parameters. Use 10-12% polyacrylamide gels for optimal resolution of the target protein. After transfer to PVDF membrane (nitrocellulose tends to yield lower sensitivity), block with 5% non-fat dry milk in TBST for 1 hour at room temperature. The primary antibody should be diluted 1:1000 in 2.5% BSA in TBST and incubated overnight at 4°C. Four 10-minute washes with TBST should follow before applying HRP-conjugated secondary antibody at 1:5000 dilution for 1 hour at room temperature. Chemiluminescent detection with 1-minute exposure typically yields optimal signal-to-noise ratio. Common troubleshooting issues include degradation products appearing as multiple bands, which can be minimized by adding 2 mM PMSF and 5 mM N-ethylmaleimide to all buffers .

What are the recommended conditions for immunoprecipitation of YMR046W-A?

For successful immunoprecipitation of YMR046W-A, follow this optimized protocol:

• Prepare yeast lysate in IP buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP-40, protease inhibitors)

• Pre-clear 1 mg of lysate with 30 μl Protein A/G beads for 1 hour at 4°C

• Incubate pre-cleared lysate with 4 μg YMR046W-A antibody overnight at 4°C with gentle rotation

• Add 50 μl fresh Protein A/G beads and incubate for 3 hours at 4°C

• Wash beads 4 times with IP buffer and once with PBS

• Elute bound proteins by boiling in 40 μl 2× Laemmli buffer for 5 minutes

This protocol has been optimized to maintain native protein interactions. For studying transient interactions, consider using crosslinking agents like DSP (2 mM, 30 minutes at room temperature) before cell lysis. The critical step is the antibody incubation time, as shorter periods significantly reduce yield .

How can I use YMR046W-A antibody for chromatin immunoprecipitation (ChIP) experiments?

While YMR046W-A is not primarily characterized as a DNA-binding protein, researchers investigating potential chromatin associations can adapt standard ChIP protocols with the following modifications:

• Crosslink yeast cells with 1% formaldehyde for 15 minutes at room temperature

• Quench with 125 mM glycine for 5 minutes

• Lyse cells using glass bead disruption in lysis buffer (50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, protease inhibitors)

• Sonicate chromatin to achieve fragments of 200-500 bp

• Immunoprecipitate using 5-10 μg YMR046W-A antibody per sample

• Include appropriate controls (IgG negative control, known DNA-binding protein positive control)

• Analyze by qPCR targeting promoter regions of interest

Specificity validation is crucial for ChIP applications, as non-specific chromatin binding can produce false positives. Sequential ChIP (Re-ChIP) with antibodies against known interacting partners can provide additional evidence for functional genomic associations .

Can YMR046W-A antibody be used for quantitative analysis of protein expression under different stress conditions?

Yes, YMR046W-A antibody can be effectively used for quantitative analysis of protein expression under varying stress conditions. For accurate quantification:

• Design experiments with biological triplicates for each condition

• Include loading controls (e.g., Pgk1 or Tub1) for normalization

• Maintain consistent extraction protocols across all samples

• Use graduated standard curves of recombinant protein for absolute quantification

• Apply densitometric analysis using software like ImageJ for relative quantification

The table below presents representative data showing YMR046W-A protein expression levels under different stress conditions:

This approach enables precise quantification of YMR046W-A regulation under various physiological challenges, providing insights into its functional role in stress response pathways .

How can I detect post-translational modifications of YMR046W-A using this antibody?

Detecting post-translational modifications (PTMs) of YMR046W-A requires specific approaches:

• For phosphorylation analysis:

  • Perform immunoprecipitation with YMR046W-A antibody

  • Use phospho-specific detection methods (Pro-Q Diamond staining or phospho-specific antibodies)

  • Confirm with phosphatase treatment (e.g., λ-phosphatase)

  • For precise mapping, combine with mass spectrometry

• For ubiquitination detection:

  • Add deubiquitinase inhibitors (e.g., PR-619, 20 μM) to all buffers

  • Perform IP under denaturing conditions to disrupt non-covalent interactions

  • Probe Western blots with anti-ubiquitin antibodies

• For other modifications (SUMOylation, acetylation):

  • Utilize specific inhibitors during extraction (e.g., deacetylase inhibitors like TSA)

  • Perform dual IP with modification-specific antibodies

  • Validate with recombinant enzymes that remove specific modifications

Note that the standard YMR046W-A antibody recognizes the protein regardless of most PTMs, but epitope masking can occur with modifications at or near the antibody binding site. Consider using alternative antibodies recognizing different epitopes for comprehensive PTM analysis .

What are common causes of false-negative results when using YMR046W-A antibody?

Several factors can contribute to false-negative results when working with YMR046W-A antibody:

• Protein extraction issues:

  • Insufficient cell disruption (increase bead-beating cycles)

  • Inappropriate buffer composition (ensure detergent compatibility)

  • Protein degradation (verify protease inhibitor effectiveness)

• Antibody-related factors:

  • Epitope masking by protein interactions or conformational changes

  • Denaturation of antibody during storage or handling

  • Batch-to-batch variability affecting specificity

• Technical parameters:

  • Insufficient transfer efficiency in Western blotting

  • Excessive washing stringency

  • Inappropriate blocking agents (test alternative blockers)

  • Detection system sensitivity limitations

To troubleshoot false negatives, implement positive controls using recombinant YMR046W-A protein, test different extraction methods, and validate antibody activity against known positive samples. Additionally, consider performing dot blots with denatured protein to confirm antibody reactivity independent of electrophoresis and transfer steps .

How can I distinguish between specific and non-specific bands when analyzing YMR046W-A by Western blot?

Distinguishing between specific and non-specific bands requires systematic validation:

• Molecular weight verification:

  • YMR046W-A has a predicted molecular weight of X kDa (varies by strain)

  • Post-translational modifications may cause apparent shifts

  • Compare observed vs. predicted molecular weights

• Validation controls:

  • Use YMR046W-A knockout strain as negative control

  • Test peptide competition (pre-incubation with immunizing peptide)

  • Compare pattern across different antibody lots or clones

• Enhanced specificity techniques:

  • Gradient gels for better resolution

  • Longer running times to separate closely migrating bands

  • Two-dimensional electrophoresis for complex samples

• Signal verification:

  • Correlate band intensity with expected expression patterns

  • Compare detection across different cell states/conditions

The table below outlines common cross-reactive bands observed with YMR046W-A antibody and strategies to differentiate them:

This information helps researchers correctly identify the specific YMR046W-A signal among potential artifacts .

What are the critical parameters affecting the sensitivity and specificity of YMR046W-A detection?

The critical parameters affecting YMR046W-A detection sensitivity and specificity include:

• Sample preparation factors:

  • Growth phase (expression peaks at mid-log phase)

  • Extraction buffer composition (ionic strength, detergent type)

  • Protein denaturation method (heat vs. chemical)

  • Fresh vs. frozen samples (avoid multiple freeze-thaw cycles)

• Technical parameters:

  • Antibody dilution (optimal range: 1:500-1:2000)

  • Incubation time and temperature (overnight at 4°C recommended)

  • Blocking agent compatibility (BSA vs. milk)

  • Secondary antibody selection (species-matched, minimal cross-reactivity)

  • Washing stringency (TBST concentration, duration)

• Detection system considerations:

  • Chemiluminescent vs. fluorescent detection

  • Exposure time optimization

  • Signal amplification systems

Systematic optimization of these parameters should follow a factorial design approach, first optimizing major variables (antibody concentration, blocking agent) before fine-tuning secondary parameters. The detection limit can be improved approximately 3-5 fold through careful optimization of these conditions .

How does antibody detection of YMR046W-A compare across different yeast strains?

YMR046W-A detection efficiency varies across different Saccharomyces cerevisiae strains due to genetic polymorphisms and expression differences:

These strain-specific differences highlight the importance of validation when working with non-standard yeast strains. Sequence alignment analysis between strains can help predict potential epitope variations affecting antibody recognition. For industrial or wild yeast strains, preliminary testing is strongly recommended before designing extensive experiments .

What complementary techniques should be used alongside YMR046W-A antibody for comprehensive protein analysis?

A multi-technique approach provides the most robust analysis of YMR046W-A:

• Expression analysis:

  • RT-qPCR for mRNA expression correlation

  • Ribosome profiling for translation efficiency

  • Mass spectrometry for absolute quantification

  • GFP/RFP tagging for live-cell visualization

• Functional characterization:

  • Yeast two-hybrid for interaction partners

  • Co-immunoprecipitation for complex identification

  • Chromatin association analysis (if relevant)

  • Phenotypic analysis of knockout/overexpression strains

• Structural insights:

  • Limited proteolysis combined with Western blot

  • Conformational antibodies for structure analysis

  • Mass spectrometry for PTM mapping

This integrated approach overcomes the limitations of any single technique. For example, combining antibody-based detection with MS/MS analysis can validate specificity while providing additional information about modifications and interaction partners not detectable by antibodies alone .

How should research data using YMR046W-A antibody be interpreted in light of potential cross-reactivity?

When interpreting research data, consider the following guidelines to account for potential cross-reactivity:

• Validation requirements:

  • Establish baseline detection in wild-type vs. knockout strains

  • Document all bands observed, not just the expected one

  • Verify consistency across experimental replicates

  • Perform parallel detection with alternative methods

• Data interpretation frameworks:

  • Apply statistical analysis to distinguish signal from noise

  • Consider relative changes rather than absolute values

  • Implement correction factors based on validation experiments

  • Document limitations in manuscripts

• Comparative analysis strategies:

  • Use multiple antibodies targeting different epitopes

  • Apply orthogonal techniques for confirmation

  • Establish dose-response relationships where applicable

  • Consider kinetic measurements over single time points

When publishing results using YMR046W-A antibody, transparency about validation methods, detailed experimental protocols, and acknowledgment of potential limitations significantly enhances data reliability and reproducibility. Consider including supplementary data showing validation experiments alongside primary results .